{"slug":"what-are-peptides-glp-1","verification":{"valid":true,"entries":2,"head":"88489f6898e628cf1ceb7146ef267cf88b4fd4658970916a00253f724cb920ff"},"energy":{"passes":2,"tokens_in":20056,"tokens_out":3556,"tokens_total":23612,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"88489f6898e628cf1ceb7146ef267cf88b4fd4658970916a00253f724cb920ff"},"provenance":[{"ts":"2026-06-29T22:02:02.647Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: What Are Peptides for Glp 1\nSlug: what-are-peptides-glp-1\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[],\"drug_chains\":[{\"drug\":\"glp1-agonists\",\"name\":\"GLP-1 agonists (class)\",\"section_title\":\"Why GLP-1 agonists (class) matters for you\",\"steps\":[\"**Drug:** GLP-1 agonists (class)\",\"**What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"],\"prose\":\"1. **Drug:** GLP-1 agonists (class)\\n2. **What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\\n3. **Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"}],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\",\"section_headings\":[\"What's breaking down\",\"Why GLP-1 agonists (class) matters for you\",","response":"{\n  \"slug\": \"what-are-peptides-glp-1\",\n  \"title\": \"What Are Peptides for GLP-1? Evidence on Agonists like Semaglutide and Tirzepatide\",\n  \"body\": \"## What's breaking down\\n\\nGLP-1 refers to glucagon-like peptide-1, a hormone your body releases after eating. It signals the pancreas to release insulin, slows stomach emptying, and tells the brain you are full. Over time or with excess weight, this natural signaling can weaken. Food intake stays high. Blood sugar control slips. Fat storage continues. The result is a cycle where metabolic repair pathways lag behind ongoing breakdown from overeating and inflammation.\\n\\nNo single tissue fails first. The gut-brain axis, pancreatic response, and energy balance all drift. GLP-1 agonist medications are synthetic peptides designed to mimic and strengthen that signal. They are not natural repair compounds. They alter metabolism to support weight reduction and glucose control.\\n\\n## Why GLP-1 agonists (class) matters for you\\n\\n1. **Drug:** GLP-1 agonists (class) — examples include semaglutide and the dual GIP/GLP-1 agonist tirzepatide. These are injectable or oral peptide analogs.\\n2. **What it does:** They bind GLP-1 receptors (and GIP receptors for tirzepatide). This increases insulin release when glucose is high, reduces glucagon, slows gastric emptying, and increases satiety via brain pathways. Average weight loss in trials reaches 15-21% of body weight over 1-2 years. Metabolic benefits include better glycemic control. Tradeoffs appear with rapid loss: possible lean mass reduction and gastrointestinal slowing.\\n3. **Therefore for you:** The drug supports metabolism by lowering appetite and improving insulin dynamics. It does not directly repair tissues. Weight reduction can reduce mechanical load on joints and spine (roughly 4 pounds less compressive force per pound lost in the lumbar area during standing). This indirect unloading may ease strain if excess weight contributes to degeneration. However, rapid loss may trade o","tokens_in":20056,"tokens_out":3556,"cost":0,"prev":"genesis","hash":"e04000cfb1acf09387cc20cbb2a9cecfd8bf280fe58643424b68ba0a2ea8b3bd"},{"ts":"2026-07-17T02:43:31.625Z","model":"owner","action":"voxel_divide","prompt":"","input":"what-are-peptides-glp-1","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e04000cfb1acf09387cc20cbb2a9cecfd8bf280fe58643424b68ba0a2ea8b3bd","hash":"88489f6898e628cf1ceb7146ef267cf88b4fd4658970916a00253f724cb920ff"}]}